CVS Health Corporation (CVS) currently holds a consensus from Wall Street analysts, with 20 out of 24 experts recommending it as a top pick as of late April 2026. Trading near $78.38 , the stock is widely considered an attractive value play due to its low valuation relative to its $400+ billion annual revenue and robust cash flow. Key Investment Highlights
: CVS offers a 3.4% dividend yield , which is more than double the S&P 500 average. should i buy cvs stock
: The company is still managing significant debt from past major acquisitions, such as Aetna. Summary of Analyst Sentiment (April 2026) Percentage Strong Buy Buy Hold/Sell CVS Health Corporation (CVS) currently holds a consensus
: The acquisition of assets from bankrupt rival Rite Aid has added roughly 9 million new patients to its pharmacy network. Potential Risks to Consider : The company is still managing significant debt